Pharmaron Sets 20 August 2026 Board Meeting to Approve 1H 2026 Interim Results

Bulletin Express08-06

Pharmaron Beijing Co., Ltd. (Pharmaron) has issued a notice confirming that its board of directors will convene on 20 August 2026 to consider and approve the consolidated interim results for the six months ended 30 June 2026 and to authorize their publication.

The announcement, dated 6 August 2026 and signed by Chairman Dr. Lou Boliang, specifies that the session will take place in Beijing, the People’s Republic of China.

Pharmaron’s current board composition comprises: • Executive Directors: Dr. Lou Boliang, Mr. Lou Xiaoqiang, Ms. Zheng Bei • Employee Representative Director: Mr. Li Shing Chung Gilbert • Non-executive Director: Ms. Wan Xuan • Independent Non-executive Directors: Ms. Li Lihua, Prof. Tsang King Fung, Ms. Shen Rong

No additional financial details were disclosed in the notice. The forthcoming meeting will determine the release timetable and content of Pharmaron’s half-year financial statements for 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1182061725?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-06 16:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182061725","market":"hk","top_or_hot":-1,"title":"Pharmaron Sets 20 August 2026 Board Meeting to Approve 1H 2026 Interim Results","media":"Bulletin Express","content":"<p>Pharmaron Beijing Co., Ltd. (Pharmaron) has issued a notice confirming that its board of directors will convene on 20 August 2026 to consider and approve the consolidated interim results for the six months ended 30 June 2026 and to authorize their publication.</p>\n<p>The announcement, dated 6 August 2026 and signed by Chairman Dr. Lou Boliang, specifies that the session will take place in Beijing, the People’s Republic of China.</p>\n<p>Pharmaron’s current board composition comprises:\n• Executive Directors: Dr. Lou Boliang, Mr. Lou Xiaoqiang, Ms. Zheng Bei  \n• Employee Representative Director: Mr. Li Shing Chung Gilbert  \n• Non-executive Director: Ms. Wan Xuan  \n• Independent Non-executive Directors: Ms. Li Lihua, Prof. Tsang King Fung, Ms. Shen Rong</p>\n<p>No additional financial details were disclosed in the notice. The forthcoming meeting will determine the release timetable and content of Pharmaron’s half-year financial statements for 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Sets 20 August 2026 Board Meeting to Approve 1H 2026 Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Sets 20 August 2026 Board Meeting to Approve 1H 2026 Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-06 16:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron Beijing Co., Ltd. (Pharmaron) has issued a notice confirming that its board of directors will convene on 20 August 2026 to consider and approve the consolidated interim results for the six months ended 30 June 2026 and to authorize their publication.</p>\n<p>The announcement, dated 6 August 2026 and signed by Chairman Dr. Lou Boliang, specifies that the session will take place in Beijing, the People’s Republic of China.</p>\n<p>Pharmaron’s current board composition comprises:\n• Executive Directors: Dr. Lou Boliang, Mr. Lou Xiaoqiang, Ms. Zheng Bei  \n• Employee Representative Director: Mr. Li Shing Chung Gilbert  \n• Non-executive Director: Ms. Wan Xuan  \n• Independent Non-executive Directors: Ms. Li Lihua, Prof. Tsang King Fung, Ms. Shen Rong</p>\n<p>No additional financial details were disclosed in the notice. The forthcoming meeting will determine the release timetable and content of Pharmaron’s half-year financial statements for 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1182061725","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182061725","pubTimestamp":1786005958,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Pharmaron Beijing Co., Ltd. (Pharmaron) has issued a notice confirming that its board of directors will convene on 20 August 2026 to consider and approve the consolidated interim results for the six...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"康龙化成将于 2026 年 8 月 20 日召开董事会会议，批准 2026 年上半年中期业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"Pharmaron Beijing Co., Ltd. (Pharmaron) has issued a notice confirming that its board of directors will convene on 20 August 2026 to consider and approve the consolidated interim results for the six months ended 30 June 2026 and to authorize their publication.\nThe announcement, dated 6 August 2026 and signed by Chairman Dr. Lou Boliang, specifies that the session will take place in Beijing, the People’s Republic of China.\nPharmaron’s current board composition comprises:\n• Executive Directors: Dr. Lou Boliang, Mr. Lou Xiaoqiang, Ms. Zheng Bei  \n• Employee Representative Director: Mr. Li Shing Chung Gilbert  \n• Non-executive Director: Ms. Wan Xuan  \n• Independent Non-executive Directors: Ms. Li Lihua, Prof. Tsang King Fung, Ms. Shen Rong\nNo additional financial details were disclosed in the notice. The forthcoming meeting will determine the release timetable and content of Pharmaron’s half-year financial statements for 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1182061725","isCrawlerRequest":true}